FIELD: chemistry.
SUBSTANCE: invention provides a composition having antioxidant properties in the form of a tablet, comprising an active agent based on nicotinamide adenine dinucleotide in reduced form (NADH) and inert filling agents, characterised by that the active ingredient is a complex which is a mixture of 10 wt % NADH with 63 wt % vegetable fats, 17 wt % beeswax and 10 wt % chlorophyll, and the inert filling agents are in the form of microcrystalline cellulose, Macrogol 6000, intense sweetener and a food flavourant.
EFFECT: invention provides a new tablet form of NADH.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORALLY DISINTEGRATING TABLET OF DEHYDROEPIANDROSTERONE AND/OR COMBINATION OF DEHYDROEPIANDROSTERONE AND L-THEANINE | 2014 |
|
RU2557960C1 |
| ORALLY DISPERSIBLE TABLET OF DEHYDROEPIANDROSTERONE | 2014 |
|
RU2545812C1 |
| NEW THERAPEUTIC COMPOSITION FOR TREATING PAIN SYNDROME ACCOMPANYING SMOOTH MUSCLE SPASM | 2012 |
|
RU2497505C1 |
| DRUG PREPARATION IN FORM OF ORALLY DISPERSIBLE TABLET AND METHOD FOR MAKING DRUG PREPARATION | 2012 |
|
RU2503447C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
| BIOLOGICALLY ACTIVE COMPOSITION IN FORM OF LOZENGE | 2015 |
|
RU2613180C2 |
| COMBINATION FOR PREVENTION, CORRECTION AND THERAPY OF PAIN RELATED TO NEURODEGENERATION OR ASSOCIATED WITH SOMATOFORM DISORDERS | 2013 |
|
RU2506077C1 |
| PHARMACEUTICAL COMPOSITION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2384336C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| KIT FOR APPETITE CONTROL AND BODY WEIGHT NORMALIZATION AND METHOD OF ITS APPLICATION | 2019 |
|
RU2722728C1 |
